GMED vs. PEN: Which Stock Should Value Investors Buy Now?
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
GMED or PEN: Which Is the Better Value Stock Right Now?
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
Artisan Small Cap Fund Q1 2026 Portfolio Activity
Penumbra (PEN) Misses Q1 Earnings Estimates
Penumbra, Inc. Reports First Quarter 2026 Financial Results
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
Here's Why Penumbra (PEN) is a Strong Growth Stock
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Penumbra (NYSE:PEN) Director Harpreet Grewal Sells 100 Shares
Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Congress Asset Management Co. Trims Stake in Penumbra, Inc. $PEN
Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Hold” by Brokerages
Penumbra (NYSE:PEN) & Lombard Medical (OTCMKTS:EVARF) Head-To-Head Survey
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Bamco Inc. NY Has $3.42 Million Position in Penumbra, Inc. $PEN
Blair William & Co. IL Sells 2,456 Shares of Penumbra, Inc. $PEN
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
Artisan Partners Limited Partnership Raises Position in Penumbra, Inc. $PEN
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
CLPBY or PEN: Which Is the Better Value Stock Right Now?
Boston Scientific announces results for fourth quarter and full year 2025
GMED vs. PEN: Which Stock Is the Better Value Option?
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
Hussman Strategic Advisors Inc. Makes New Investment in Penumbra, Inc. $PEN
Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights
Artisan Small Cap Fund Q4 2025 Portfolio Activity
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, CVGW, AVO Shareholders to Contact the Firm to Discuss Their Rights
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Penumbra (PEN) Moves 11.8% Higher: Will This Strength Last?
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)
Boston Scientific's $14.5B Acquisition of Penumbra Raises Investor Concerns
Boston Scientific to acquire Penumbra in $14.5B deal
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders
Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal
Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach